Mark A. Glickman

Insider Reports History

Location
Ann Arbor, MI
Signature
/s/ Phillip Torrence, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark A. Glickman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MetaVia Inc. Director Common Stock 37.9K $28.4K $0.75 30 Jun 2025 Direct
TherapeuticsMD, Inc. Co-Chief Executive Officer Restricted Stock Units 3.47K $12.6K $3.64 06 Dec 2022 Direct
TherapeuticsMD, Inc. Co-Chief Executive Officer Common Stock 1.29K $2.9K $2.24 06 Dec 2022 Direct

Insider Reports Filed by Mark A. Glickman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MTVA MetaVia Inc. 30 Jun 2025 1 $0 4 Director 01 Jul 2025, 16:03
NRBO NeuroBo Pharmaceuticals, Inc. 07 Jun 2024 1 $0 4 Director 07 Jun 2024, 19:25
NRBO NeuroBo Pharmaceuticals, Inc. 27 Jul 2023 2 $0 4 Director 28 Jul 2023, 06:11
NRBO NeuroBo Pharmaceuticals, Inc. 11 May 2023 0 $0 3 Director 12 May 2023, 09:44
TXMD TherapeuticsMD, Inc. 06 Dec 2022 3 -$2.17K 4 Co-Chief Executive Officer 09 Dec 2022, 18:38
TXMD TherapeuticsMD, Inc. 31 Mar 2022 1 $0 4 Chief Business Officer 31 Mar 2022, 17:15
TXMD TherapeuticsMD, Inc. 23 Mar 2022 1 $0 4 Chief Business Officer 28 Mar 2022, 07:00
TXMD TherapeuticsMD, Inc. 15 Oct 2021 3 $0 4 Chief Business Officer 15 Oct 2021, 17:20
TXMD TherapeuticsMD, Inc. 15 Oct 2021 0 $0 3 Chief Business Officer 15 Oct 2021, 17:15